Thus, THRB-linked processes and the association between hypothyroidism and NRAS-mutant melanoma should be further experimentally validated, as thyroid hormone therapy might be a novel strategy for NRAS-mutant melanoma treatment. The gene discussed is THRB; the disease is melanoma.